Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

190.01
+1.070.57%
Post-market: 189.64-0.3700-0.19%19:59 EDT
Volume:10.29M
Turnover:1.94B
Market Cap:75.86B
PE:-23.73
High:193.72
Open:190.26
Low:183.28
Close:188.94
52wk High:208.90
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.67
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:11.22
PE(LYR):-26.17

Loading ...

Moderna’s Gain Widens To 150%, MRK Rises More Than 12%, BioNTech Climbs Over 24%

Tiger Newspress
·
Aug 19

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) and Merck & Company (MRK)

TIPRANKS
·
Aug 19

Moderna up over 90%, on Track for Record Percent Increase

Dow Jones
·
Aug 19

Moderna Stock Price Doubles on Melanoma Vaccine News

Dow Jones
·
Aug 19

Moderna upgraded, Baidu downgraded: Wall Street’s top analyst calls

TIPRANKS
·
Aug 19

U.S. Stocks Surge at Open as Treasury Expands Buyback Program

Deep News
·
Aug 19

Moderna Shares Jump Nearly 100%, Set for Biggest One-Day Percentage Gain on Record

THOMSON REUTERS
·
Aug 19

Shares of Moderna Rise 87%, Merck Rise 6.8% After Skin Cancer Vaccine Succeeds in Late-Stage Trial

THOMSON REUTERS
·
Aug 19

U.S. Stocks Open Higher; Nasdaq Gains 0.3%, MRNA Surges 90%, Marvell Rises over 10%, SK Hynix Climbs 5%

Tiger Newspress
·
Aug 19

US Opening Bell | Stocks open higher; Moderna, Inc. soars 84%; Biotech and chip stocks rally

US Opening Bell
·
Aug 19

Movement Alert|Moderna, Inc. Surges 85.9% in Regular Trading, Phase III mRNA Cancer Vaccine Trial Achieves Primary Endpoint

Market Focus
·
Aug 19

Sector Update: Healthcare

MT Newswires Live
·
Aug 19

William Blair Upgrades Moderna to Outperform From Market Perform

MT Newswires Live
·
Aug 19

US Stocks-Wall St Set for Higher Open After Retail Earnings; Moderna Soars

Reuters
·
Aug 19

Moderna extends rally, shares up 89% to $118.99 after melonoma data

TIPRANKS
·
Aug 19

Moderna upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

The "Holy Grail" Of Cancer Treatment? Moderna's Melanoma MRNA Vaccine Succeeds In Phase 3 Trial

Options & Short Sell
·
Aug 19

Moderna Shares More than Double Premarket; Last up 103%

THOMSON REUTERS
·
Aug 19